cyclopentane has been researched along with Pancreatic Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuang, T; Li, JA; Lou, W; Mao, W; Rong, Y; Zhang, L | 1 |
| Chen, SY; Chen, YY; Hong, CJ; Hsu, YH; Wang, SY; Yen, GC | 1 |
| Kuang, T; Li, JA; Lou, W; Lou, Z; Luo, K; Nowsheen, S; Qin, B; Rong, Y; Song, C; Wang, D; Xu, X; Yuan, J | 1 |
| Chen, P; Cheng, H; Chu, YW; Hoffman, RM; Hua, ZC; Jeong, LS; Jia, LJ; Jiang, YN; Lee, HW; Li, LH; Qi, H; Wang, K; Wang, P; Wang, R; Wu, JF; Yang, M; Yao, WT; Ying, HQ; Yu, GY; Yu, J; Yu, XJ | 1 |
| Karnak, D; Lawrence, TS; Morgan, MA; Sun, Y; Tan, M; Zhang, Q | 1 |
| Lawrence, TS; Li, H; Morgan, MA; Sebolt, JT; Smith, PG; Sun, Y; Wei, D; Yu, J; Zhao, L | 1 |
| Dériaz, N; Gérard, N; Thorens, B | 1 |
| De Neve, WJ; Delvaeye, MM; Scheper, RJ; Storme, GA; Van den Berge, DL; Verovski, VN | 1 |
8 other study(ies) available for cyclopentane and Pancreatic Neoplasms
| Article | Year |
|---|---|
Gene expression profiling reveals the genomic changes caused by MLN4924 and the sensitizing effects of NAPEPLD knockdown in pancreatic cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cyclopentanes; Gene Expression Profiling; Mice; Pancreatic Neoplasms; Pyrimidines | 2022 |
Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cyclopentanes; HMGB1 Protein; Humans; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor for Advanced Glycation End Products; Signal Transduction | 2022 |
Chk1 inhibitor SCH 900776 enhances the antitumor activity of MLN4924 on pancreatic cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Checkpoint Kinase 1; Cyclopentanes; DNA Damage; DNA Replication; Drug Synergism; Female; G2 Phase Cell Cycle Checkpoints; Humans; Male; Mice, Nude; Middle Aged; Pancreatic Neoplasms; Prognosis; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Ubiquitin-Activating Enzymes | 2018 |
Suppression of tumor angiogenesis by targeting the protein neddylation pathway.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Carrier Proteins; Cell Cycle Checkpoints; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Cullin Proteins; Cyclopentanes; DNA Damage; Dose-Response Relationship, Drug; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Nude; NEDD8 Protein; Neovascularization, Pathologic; Neovascularization, Physiologic; Pancreatic Neoplasms; Protein Processing, Post-Translational; Pyrimidines; Rats; Rats, Sprague-Dawley; rhoA GTP-Binding Protein; RNA Interference; Time Factors; Tissue Culture Techniques; Transfection; Tumor Burden; Ubiquitin-Activating Enzymes; Ubiquitins; Xenograft Model Antitumor Assays | 2014 |
FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4.
Topics: Amino Acid Sequence; Animals; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cyclopentanes; DNA Breaks, Double-Stranded; DNA End-Joining Repair; DNA-Activated Protein Kinase; DNA-Binding Proteins; Enzyme Inhibitors; F-Box Proteins; F-Box-WD Repeat-Containing Protein 7; HCT116 Cells; Humans; Lysine; Mice, Knockout; Molecular Sequence Data; Nuclear Proteins; Pancreatic Neoplasms; Phosphorylation; Polyubiquitin; Protein Processing, Post-Translational; Pyrimidines; Radiation Tolerance; Radiation-Sensitizing Agents; RNA Interference; Time Factors; Transfection; Ubiquitin-Activating Enzymes; Ubiquitin-Protein Ligases; Ubiquitination; Ubiquitins | 2016 |
Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor.
Topics: Aneuploidy; Animals; Base Sequence; Cell Division; Cell Line, Tumor; Cyclopentanes; DNA Damage; Enzyme Inhibitors; Fluorescent Antibody Technique; G2 Phase; Humans; NEDD8 Protein; Pancreatic Neoplasms; Pyrimidines; Radiation Tolerance; RNA, Small Interfering; Ubiquitins; Xenograft Model Antitumor Assays | 2012 |
GLUT2 surface expression and intracellular transport via the constitutive pathway in pancreatic beta cells and insulinoma: evidence for a block in trans-Golgi network exit by brefeldin A.
Topics: Animals; Blotting, Western; Brefeldin A; Cell Line; Cell Membrane; Cells, Cultured; Cyclopentanes; Glucose Transporter Type 2; Golgi Apparatus; Insulinoma; Islets of Langerhans; Kinetics; Monosaccharide Transport Proteins; Pancreatic Neoplasms; Protein Processing, Post-Translational; Protein Structure, Secondary; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; Trypsin; Tumor Cells, Cultured | 1993 |
Low-level doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1/ADR cells implicates a brefeldin A-sensitive mechanism of drug extrusion.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brefeldin A; Cyclopentanes; Doxorubicin; Drug Resistance, Multiple; Flow Cytometry; GTP-Binding Proteins; Humans; Pancreatic Neoplasms; Tumor Cells, Cultured; Verapamil | 1996 |